Recombinant ERBB2 (Coprelotamab Biosimilar) antibody

Catalog No. ABIN7675924

The Human Monoclonal anti-ERBB2 (Coprelotamab Biosimilar) antibody is suitable to detect ERBB2 (Coprelotamab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant ERBB2 (Coprelotamab Biosimilar) antibody (ABIN7675924)

Target: ERBB2 (Coprelotamab Biosimilar) (ErbB2/Her2 (Coprelotamab Biosimilar))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ERBB2 (Coprelotamab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-ERBB2 (Coprelotamab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab)

Characteristics: Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for ERBB2 (Coprelotamab Biosimilar)

Target: ERBB2 (Coprelotamab Biosimilar) (ErbB2/Her2 (Coprelotamab Biosimilar))

Alternative Name: ERBB2 (Coprelotamab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P04626